Topical imiquimod treatment of lentigo maligna: Clinical and histologic evaluation

Journal of the American Academy of Dermatology

Volumn 51, Issue 4, 2004, Pages 635-639

  Kupfer Bessaguet, I ^a   Guillet, G ^a   Misery, L ^a   Carre, J L ^a   Leroy, J P ^a   Sassolas, Bruno ^a,b  

^a CHU MORVAN   (France)

^b 5 Avenue Foch 29609 Brest France ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; MALE; MALIGNANT LENTIGO; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; BIOPSY; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HUTCHINSON'S MELANOTIC FRECKLE; MALE; SKIN; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 4644275846     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2004.05.004     Document Type: Article

References (17)

1. D.J. Eedy Imiquimod: a potential role in dermatology? Br J Dermatol 147 2002 1 6
2. G. Von Krogh Management of anogenital warts (condylomata acuminata) Eur J Dermatol 11 2001 598 604
3. L.M. Imbertson, J.M. Beaurline, and A.M. Couture Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463 J Invest Dermatol 110 1998 734 739
4. T.L. Wagner, C.L. Ahonen, A.M. Couture, S.J. Gibson, R.L. Miller, and R.M. Smith Modulation of TH1 and TH2 cytokine production with the immune response modifiers R-848 and imiquimod Cell Immunol 191 1999 9 19
5. K.R. Beutner, J.K. Geisse, D. Helman, T.L. Fox, A. Ginkel, and M.L. Owens Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream J Am Acad Dermatol 41 1999 1002 1007
6. R. Marks, K. Gebauer, S. Shumack, M. Amies, J. Bryden, T.L. Fox, and M.L. Owens The Australasian Multicentre Trial Group. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial J Am Acad Dermatol 44 2001 807 813
7. E. Stockfleth, T. Meyer, B. Benninghoff, and E. Christofers Successful treatment of actinic keratosis with imiquimod cream 5%: A report of six cases Br J Dermatol 144 2001 1050 1053
8. U.R. Hengge, and R. Stark Topical imiquimod to treat intraepidermal carcinoma Arch Dermatol 137 2001 709 711
9. A. Mackenzie-Wood, S. Kossard, J. Launey, B. Wilkinson, and M.L. Owens Imiquimod 5% cream in the treatment of Bowen's disease J Am Acad Dermatol 44 2001 462 470
10. C. Diaz-Arrastia, I. Arany, S.C. Robazetti, T.V. Dinh, Z. Gatalica, and S.K. Tyring Clinical and molecular responses in high-grade intraepithelial neoplasia treated with imiquimod 5% Clin Cancer Res 7 2001 3031 3033
11. M. Kaspari, R. Gutzmer, P. Kiehl, P. Dumke, A. Kapp, and J.P. Brodersen Imiquimod 5% cream in the treatment of human papillomavirus-16-positive erythroplasia of Queyrat Dermatology 205 2002 67 69
12. F. Cook-Bolden, and J.M. Weinberg Topical imiquimod 5% cream in the treatment of Bowen's disease of the penis J Am Acad Dermatol 46 2002 146 147
13. R. Gutzmer, M. Kaspari, M. Vogelbruch, P. Kiehl, A. Kapp, and T. Werfel Successful treatment of anogenital Bowen's disease with the immunomodulator imiquimod, and monitoring of therapy by DNA image cytometry Br J Dermatol 147 2002 160 165
14. A. Steinmann, J.O. Funk, G. Schuler, and P. Von Den Driesch Topical imiquimod treatment of a cutaneous melanoma metastasis J Am Acad Dermatol 43 2000 555 556
15. S. Ugurel, A. Wagner, C. Pföhler, W. Tilgen, and U. Reinhold Topical imiquimod eradicates skin metastases of malignant melanoma but fails to prevent rapid lymphogenous metastatic spread Br J Dermatol 2002 621 624
16. P. Ormond, C. Blasdale, N. Leonard, and C.M. Lawrence Treatment of lentigo maligna with imiquimod Br J Dermatol 147 2002 57
17. I. Ahmed, and J. Berth-Jones Imiquimod: a novel treatment for lentigo maligna Br J Dermatol 143 2000 843 845